Apogee Therapeutics Inc (APGE)

Apr 13, 2026

Apogee Therapeutics Insider Sold Shares Worth $1,651,664, According to a Recent SEC Filing - Moomoo

Apr 13, 2026

Apr 12, 2026

Apogee Therapeutics rises on positive phase 2 data for Zumilokibart in atopic dermatitis - MSN

Apr 12, 2026

Apr 12, 2026

How Investors May Respond To Apogee Therapeutics (APGE) CEO Share Sale and US$403 Million Equity Raise - Sahm

Apr 12, 2026

Apr 11, 2026

Aug PreEarnings: Will Apogee Therapeutics Inc benefit from seasonalityPortfolio Return Report & Expert Approved Trade Ideas - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Dow Update: Should value investors consider Apogee Therapeutics IncQuarterly Market Summary & Accurate Technical Buy Alerts - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Apogee Therapeutics CEO Henderson sells $1.65 million in stock By Investing.com - Investing.com Australia

Apr 10, 2026

Apr 10, 2026

Apogee Therapeutics CEO Henderson sells $1.65 million in stock - Investing.com

Apr 10, 2026

Apr 10, 2026

Apogee Therapeutics (APGE) CEO sells 20,000 shares under Rule 10b5-1 plan - Stock Titan

Apr 10, 2026

Apr 09, 2026

Apogee Therapeutics stock hits all-time high at 85.95 USD By Investing.com - Investing.com Australia

Apr 09, 2026

Apr 09, 2026

Apogee Therapeutics stock hits all-time high at 85.95 USD - Investing.com

Apr 09, 2026

Apr 08, 2026

T. Rowe Price (APGE) discloses 10.29M shares, 16.8% stake in Apogee - Stock Titan

Apr 08, 2026

Apr 07, 2026

Trade Recap: Whats the beta of Apogee Therapeutics Inc stockWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

APGE Earnings History & Surprises | EPS & Revenue Results | APOGEE THERAPEUTICS INC (NASDAQ:APGE) - ChartMill

Apr 07, 2026

Apr 03, 2026

Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus

Apr 03, 2026

Apr 03, 2026

Apogee Therapeutics (APGE) CMO sells shares worth $466,619 By Investing.com - Investing.com Canada

Apr 03, 2026

Apr 03, 2026

Apogee Therapeutics (APGE) CMO sells shares worth $466,619 - Investing.com

Apr 03, 2026

Apr 03, 2026

Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock - MarketBeat

Apr 03, 2026

Apr 03, 2026

Apogee Therapeutics (APGE) CMO trades 5,500 shares under 10b5-1 plan - Stock Titan

Apr 03, 2026

Apr 03, 2026

Responsive Playbooks and the APGE Inflection - Stock Traders Daily

Apr 03, 2026

Apr 03, 2026

APGE Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026

Apr 03, 2026

Mizuho Initiates Coverage of Apogee Therapeutics (APGE) with Outperform Recommendation - MSN

Apr 03, 2026

Apr 03, 2026

Banque Pictet & Cie SA Invests $3.16 Million in Apogee Therapeutics Inc. $APGE - MarketBeat

Apr 03, 2026

Apr 02, 2026

Apogee Therapeutics CMO sells $361,860 in shares - Investing.com

Apr 02, 2026

Apr 02, 2026

Deutsche Bank Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $118 - Moomoo

Apr 02, 2026

Apr 02, 2026

SG Americas Securities LLC Sells 60,964 Shares of Apogee Therapeutics Inc. $APGE - marketbeat.com

Apr 02, 2026

Apr 01, 2026

Fairmount Funds Management LLC Increases Stake in Apogee Therape - GuruFocus

Apr 01, 2026

Apr 01, 2026

Apogee Therapeutics (NASDAQ:APGE) Sets New 52-Week HighHere's What Happened - MarketBeat

Apr 01, 2026

Mar 31, 2026

Apogee Therapeutics prices upsized $350M offering at $70 a share - MSN

Mar 31, 2026

Mar 31, 2026

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $137 - Moomoo

Mar 31, 2026

Mar 30, 2026

APGE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 30, 2026

Mar 30, 2026

Market Rankings: Will Apogee Therapeutics Inc benefit from seasonalityEarnings Recap Summary & Weekly Setup with ROI Potential - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Should Apogee Therapeutics’ (APGE) Infrequent-Dosing AD Data and $403M Equity Raise Require Investor Action? - simplywall.st

Mar 30, 2026

Mar 30, 2026

BTIG reiterates Buy on Apogee Therapeutics stock, $137 target By Investing.com - Investing.com South Africa

Mar 30, 2026

Mar 30, 2026

BTIG reiterates Buy on Apogee Therapeutics stock, $137 target - Investing.com

Mar 30, 2026

Mar 30, 2026

Apogee Therapeutics (NASDAQ:APGE) Price Target Raised to $110.00 at Mizuho - MarketBeat

Mar 30, 2026

Mar 30, 2026

Mizuho raises Apogee Therapeutics stock price target on AD data By Investing.com - Investing.com South Africa

Mar 30, 2026

Mar 30, 2026

Mizuho raises Apogee Therapeutics stock price target on AD data - Investing.com

Mar 30, 2026

Mar 30, 2026

Mizuho Securities Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Raises Target Price to $110 - Moomoo

Mar 30, 2026

Mar 29, 2026

Apogee Therapeutics announces $300 million public offering - MSN

Mar 29, 2026